Within the mammoth defense bill, the Biosecure Act has the potential to raise new hurdles for certain life sciences companies ...
As Eli Lilly gears up to support its partnered athletes, Team USA and the Games themselves at the Milano Cortina 2026 Olympic ...
After a long run of regulatory stumbles and the recent wit | "Following the withdrawal of Ocaliva from the U.S. market, we ...
As it kicks off a pivotal phase 3 trial of its investigational treatment for Angelman syndrome (AS), Ionis Pharmaceuticals is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results